Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy

Clete A. Kushida, Colin M. Shapiro, Thomas Roth, Michael J. Thorpy, Bruce C. Corser, Akinyemi O. Ajayi, Russell Rosenberg, Asim Roy, David Seiden, Jordan Dubow, Yves Dauvilliers

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy'. Together they form a unique fingerprint.

Medicine & Life Sciences